Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A new compound shows promise as a topical treatment for hair loss.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Blocking mTORC1 reduces skin tumor growth in mice.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Hedgehog pathway inhibitors could be effective in treating melanoma.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Tofacitinib might be used to treat hair loss.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.